Fierce Pharma Feature: Small molecule biomarkers in precision medicine

This contributed piece to Fierce Pharma discusses small molecule biomarkers & how next-gen mass spectrometry is enabling their discovery on an entirely new scale.

FierceBiotech's 2019 Fierce 15

Small molecules, big impact: 20 years of targeted therapy in oncology - The Lancet

AI Drug Discovery: Key Trends and Developments in Pharma Industry

Frontiers MicroRNA as an Important Target for Anticancer Drug Development

Fierce Biotech's 2022 Fierce 15

The role of precision nutrition in the modulation of microbial composition and function in people with inflammatory bowel disease - The Lancet Gastroenterology & Hepatology

Integration of personalized drug delivery systems into digital health - ScienceDirect

Plasma biomarkers for Alzheimer's disease: much needed but tough to find

Biomarker development in the precision medicine era: lung cancer as a case study